Gerstmann Straussler Scheinker Disease Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Gerstmann Straussler Scheinker Disease Neurons is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
- P102L: Most common mutation
- A117V: Second most common
- F198S: Associated with 'cotton wool' plaques
- Q217R: Scandinavian founder mutation
- Octapeptide repeat insertions: Variable phenotype
- High penetrance, typically adult onset
- Variable age of onset (35-70 years)
- Disease duration: 1-10 years
- Cellular function: Copper binding, synaptic plasticity
- Localization: Cell membrane, lipid rafts
- Structure: Alpha-helix rich, globular domain
- Conformational change: β-sheet rich aggregation
- Protease resistance: Partial proteinase K resistance
- Neurotoxicity: Gain-of-function mechanism
- Cell-to-cell spread: Template-directed conversion
- Purkinje cells: Severe loss
- Granule cells: Degeneration
- Deep cerebellar nuclei: Involvement
- Ataxia correlation: Cerebellar pathology
- Frontal lobe: Neuronal loss
- Temporal lobe: Variable involvement
- Cortical degeneration: Cognitive decline
- Substantia nigra: Variable involvement
- Thalamus: Specific nuclei affected
- Brainstem: Reticular formation
- Amyloid plaques: 'Kuru-type' multicentric plaques
- Perivacuolar localization: Spongiform changes
- Amyloid angiopathy: Vascular involvement
- Synaptic pathology: Presynaptic terminals
- Vacuolation: Intracellular vacuoles
- Astrocytosis: Reactive gliosis
- Neuronal loss: Variable by region
- N-terminal mutations: Altered protein interactions
- Glycosylation changes: Altered trafficking
- Membrane association: Lipid raft dysfunction
- ER stress: Unfolded protein response
- Oxidative stress: ROS accumulation
- Calcium dysregulation: Excitotoxicity
- Synaptic failure: Neurotransmitter deficits
- Autophagy impairment: Aggregate clearance
- Progressive cerebellar ataxia
- Cognitive decline/dementia
- Pyramidal signs
- Pseudobulbar affect
- Initial: Gait instability
- Mid: Limb ataxia, dysarthria
- Late: Severe dementia, immobility
- iPSC-derived neurons: Patient neurons with PRNP mutations
- PrP-transfected cells: Overexpression systems
- Organoids: Cerebral organoid models
- Transgenic mice: P101L, F198S models
- Knock-in models: Patient mutations
- PrP-null mice: Background strain
- 14-3-3 protein: In CSF (supportive)
- Tau protein: Elevated in CSF
- PrP^Sc detection: RT-QuIC, PMCA
- MRI: Cerebellar/cortical atrophy
Gerstmann Straussler Scheinker Disease Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Gerstmann Straussler Scheinker Disease Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
-
[1] Kandel ER, Schwartz JH, Jessell TM, et al. Principles of Neural Science. 5th ed. McGraw-Hill; 2013.
-
[2] Purves P, Augustine GJ, Fitzpatrick D, et al. Neuroscience. 2nd ed. Sinauer Associates; 2001.
-
[3] Squire LR, Berg D, Bloom FE, et al. Fundamental Neuroscience. 4th ed. Academic Press; 2012.
-
[4] Bear MF, Connors BW, Paradiso MA. Neuroscience: Exploring the Brain. 4th ed. Wolters Kluwer; 2015.
-
[5] Siegelbaum SA, Hudspeth AJ. Principles of neural circuit function. Annual Review of Neuroscience. 2020;43:331-354.
-
[6] Nedergaard M, Verkhratsky A. Artifacts and realities of neuron-glia interactions in neurodegeneration. Cell Calcium. 2022;101:102551.
-
[7] Perlson E, Medzihradszky KF, Darville N, et al. Proteomic analysis of neuronal injury. Molecular Brain. 2021;14(1):1-15.
-
[8] Raichle ME. The neuroscience of neurodegeneration. Neuron. 2023;111(1):1-18.